Fact CheckerSign in

NCT07754097Recruiting

Self-Management Data and Disease Progression in Chronic Kidney Disease

A Non-Interventional, Prospective Observational Study to Evaluate Disease Progression and Management Characteristics for the Development of an Integrated Self-Management Data Application in Chronic Kidney Disease

Source: ClinicalTrials.gov · Last updated 10 Aug 2026

Brief summary (registry, in English)

This study evaluates disease progression and management characteristics in patients with chronic kidney disease (CKD) using an integrated mobile application and hospital information system (HIS) clinical data. The main goals of this study are: 1. To observe patient self-management recording performance and adherence (continuity of recording blood pressure, blood glucose, medication, and diet). 2. To explore associations between integrated self-management data and disease progression or acute exacerbations (e.g., acute kidney injury, hyperkalemia). 3. To gather foundational evidence for optimizing and improving future digital health applications for CKD management. Participants will be recruited from outpatient clinics at Chungnam National University Hospital and followed prospectively for 1 year with regular follow-up visits.

Status (registry)
Recruiting
Study type
Observational
Enrollment
300 (estimated)
First submitted
4 Aug 2026
Start date
11 Jun 2026
Primary completion date
11 Jun 2029
Lead sponsor
Chungnam National University Hospital
NCT number
NCT07754097

What you commit to

  • Study type: Observational
  • Planned participants: 300
  • From 11 Jun 2026 to the primary completion date, 11 Jun 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients currently undergoing maintenance dialysis (hemodialysis or peritoneal dialysis) for end-stage kidney disease (ESKD).

Other

  • Patients who do not sign the informed consent form or lack the capacity to fully understand the study protocol and express voluntary consent.
  • Patients deemed unsuitable for participation in the study by the investigator.

Who the study is looking for

  • Adult patients aged 19 years or older and under 85 years.
  • Patients visiting the hospital for chronic kidney disease (CKD) management.
  • Patients diagnosed with CKD or identified as high-risk for CKD requiring continuous management (e.g., diabetes mellitus, hypertension, proteinuria, or decreased eGFR).
  • Patients capable of recording self-management data (blood pressure, diet, medication) independently or with assistance through the provided mobile application.
  • Patients whose clinical data can be collected from the Hospital Information System (HIS).

Age in the registry: 19 years to 84 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chungnam National University Hospital
Coordinator of this site? Confirm its status
DaejeonSouth KoreaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.